Skip to main content
Khiron Life Sciences Corp. logo

Khiron Life Sciences Corp. — Investor Relations & Filings

Ticker · KHRNF ISIN · CA49374L3065 LEI · 549300K2KMA7K47K2V58 TSXV Human health and social work activities
Open in API
Filings indexed 187 across all filing types
Latest filing 2023-11-18 Capital/Financing Update
Country CA Canada
Listing TSXV KHRNF

About Khiron Life Sciences Corp.

https://khiron.ca/

Khiron Life Sciences Corp. is a vertically integrated health and wellbeing company focused on the global medical cannabis market. The company specializes in the production and distribution of high-quality pharmaceutical-grade medical cannabis products. Khiron operates an integrated model encompassing Health Services, primarily through its network of medical centers (such as Clínica Zerenia), which apply principles of integrative medicine to patient care. A key component of its strategy is continuous medical education for healthcare professionals to ensure safe and effective prescription, coupled with dedicated patient follow-up programs. The company's core operations are concentrated in Latin America and Europe.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of the sale of the company's European business subsidiaries. It details the transaction terms, purchase price, and parties involved. There is no financial report, earnings data, or regulatory filing content. The document is an update on a capital transaction (sale of business units), which fits the Capital/Financing Update category. The document length is short and it is not an announcement of a report publication or a certification. Therefore, the best classification is Capital/Financing Update (CAP).
2023-11-18 English
Other material contracts (amended) - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short confirmation letter from the CFO of Medivolve Inc. addressed to multiple Canadian securities commissions. It confirms that the change of auditor notice and related letters have been reviewed by the Board and Audit Committee. The document does not contain any financial data, audit results, or detailed audit reports. It is primarily an attestation or certification regarding auditor change documentation. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than Audit Reports or Annual Reports. The document length is very short (586 characters), and it is clearly a confirmation letter rather than a full report or announcement of a report publication. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-11-17 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing an update to a proposed sale transaction involving the company's European business. It details amendments to a share purchase agreement, regulatory approvals received, management services agreements, and financing related to the transaction. There is no presentation of financial statements, earnings data, or detailed financial analysis. The document is primarily an announcement of a corporate transaction and related approvals, not a full financial report or earnings release. It also does not fit into categories like M&A filings (which are more formal merger/acquisition filings), but rather is an update on a capital transaction and financing. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2023-11-17 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a material change involving a definitive share purchase agreement for the sale of subsidiaries. It includes specifics about the transaction, regulatory approvals required, management agreements, and option agreements. The document is a formal disclosure of a material change event, typical of a material change report filed under Canadian securities regulations (NI 51-102). It is not an annual or interim financial report, audit report, earnings release, or any other type of report listed. It is a regulatory announcement about a significant corporate transaction. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-08-07 English
Other material contracts - English.pdf
M&A Activity Classification · 100% confidence The document is titled 'Share Purchase Agreement' and is a detailed legal contract between Khiron Life Sciences Corp. and 2518542 Alberta Ltd. It outlines terms for the purchase and sale of shares, including definitions, purchase price, conditions precedent, closing arrangements, indemnification, and other contractual provisions. This is a legal agreement related to a transaction involving shares, not a financial report, earnings release, or regulatory filing. It is not an announcement or summary but the full text of a transaction agreement. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids, including share purchase agreements.
2023-07-28 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that Khiron Life Sciences Corp. has entered into a definitive agreement for the sale of its European business. It details the terms of the transaction, including the sale of subsidiaries, purchase price, management agreement, option agreement, and regulatory approvals required. The document is a corporate announcement about a transaction rather than a full financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial analysis but focuses on the sale and purchase agreement and related arrangements. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2023-07-28 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.